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Abstract 
Glucagon enhances the electrical activity of pancreatic /3-cells. The mechanism of the glucagon-evoked nhancement of electrical 
activity was investigated in terms of glucose metabolism. ICR mice aged 6-12 weeks were used for experiments. Intracellular Ca 2÷ 
increased in parallel with the enhancement of electrical activity. The stimulating effect of glucagon on Ca 2+ oscillation was suppressed 
by calmodulin-antagonists (Chlorpromazine, W-7, and trifluoperazine). To trace the glucagon-evoked change in glucose metabolism, the 
reduced pyridine nucleotide (NAD(P)H) fluorescence was monitored using the microfluorometry with the excitation of 360 nm and the 
emission of 465 nm in islet cell clusters mainly consisting of /3-cells. In the presence of 2.5 mM Ca 2÷ glucagon (8.6 × 10 -8 M) 
increased the NAD(P)H fluorescence, while in the absence of Ca 2÷ the hormone had no effect on the fluorescence. Extracellular Ca 2÷ 
removal from the glucagon-containing perifusion solution decreased the fluorescence to the level which had been attained before 
glucagon was added. Chlorpromazine (10 p.M) reversed the glucagon-induced increase of NAD(P)H fluorescence as well as removing 
Ca 2+. W-7 (15 /~M) and trifluoperazine (30/xM) also suppressed the glucagon-induced increase of NAD(P)H. These results suggest that 
Ca2+/calmodulin system is involved in the acceleration of glycogenolysis by glucagon in /3-cells. On the basis of these observations, the 
mechanism of glucagon-induced nhancement of electrical activity and the relative ineffectiveness of glucagon at low glucose 
concentrations were discussed[. 
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1. Introduction 
Glucagon is known to stimulate insulin release [1,2], 
and to enhance the electrical activity of pancreatic /3-cells 
at intermediate high concentrations of glucose [3]. An 
increase of cyclic AMP (cAMP) in response to glucagon 
also has been demonstrated in isolated pancreatic /3-cells 
[4]. Forskolin, an activator of adenylate cyclase, is known 
to prolong the spike burst period [5,6], and 3-isobutyl-1- 
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methylxanthine (IBMX), an inhibitor of nucleotide diphos- 
phatase, has a similar effect on the electrical activity [6]. 
Evidence suggesting the involvement of cAMP in the 
glucagon-induced enhancement of electrical activity has 
been accumulated. It is well defined that an increase in 
intracellular cAMP activates cAMP-dependent protein ki- 
nase (PKA) [7]. Subcellular fractions phosphorylated by 
PKA in islets have been demonstrated using [3,32p]ATP 
[8], suggesting protein phosphorylation is involved in the 
regulation of electrical activity. Among the substrates of 
PKA, the ATP-sensitive K ÷ channel (K(ATP) channel) 
has been postulated as a candidate responsible for the 
enhancement of electrical activity. However, it is reported 
that a synthetic inhibitor of PKA induces a decrease in the 
K(ATP) channel activity of insulin-secreting cell lines 
RINm5F [9], namely, an inhibition of PKA results in a 
depolarization, leading to an enhancement of electrical 
activity. In the rat kidney, it has been reported that the 
exogenous addition of PKA attenuates the effect of ATP to 
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close small conductance K + channels of cortical collecting 
ducts [10]. Another study on K ÷ channels in ventricular 
myocytes has revealed that the exogenous application of 
PKA has recovered the K(ATP) channel activity after 
channel deactivation by ATP [11]. At present, there is no 
report suggesting direct involvement of activated PKA in 
closing of the K(ATP) channel. It still remains unclear 
how the activated PKA causes closure of K(ATP)channels 
in /3-cells. 
In the present study, we examined a possibility that the 
glucagon-induced nhancement of electrical activity is me- 
diated by an increase in ATP production. The increased 
cAMP may work together with Ca 2÷ to accelerate the 
phosphorolysis of stored glycogen, leading to an additional 
supply of glucose as a fuel for ATP synthesis. It has 
already been reported that reduced pyridine nucleotides 
(NAD(P)H) in /3-cells increases when extracellular glu- 
cose concentration is raised [12,13]. This observation leads 
to the following view that an additional supply of glucose 
from intracellular stores may increase the NAD(P)H pro- 
duction. Results obtained from the present study were 
favorable to this view, and strongly suggested that both 
cAMP and Ca2+/calmodulin system were involved in the 
glucagon-induced increase of NAD(P)H in /3-cells. 
2. Materials and Methods 
2.1. Animals and cell culturing 
Experiments were conducted using ICR mice aged 6-12 
weeks which were fasted for 24 h with free access to 
water. The animals were killed by cervical dislocation. The 
pancreas was immediately excised and kept in the Krebs- 
Ringer-Bicarbonate (KRB) solution. Pancreatic tissue was 
minced with scissors, and digested with collagenase (2 
mg/ml).  The operating tools were sterilized previously, 
and all solutions were passed through a filter of 0.22 /zm 
in pore size (Millipore, Bedford, USA). After the treatment 
with collagenase, islets were individually picked up using 
a small pipette under a stereo-microscope. Some islets 
were cultured in RPMI-1640 medium supplemented with 
10% fetal bovine serum, penicillin (100 I .U./ml) and 
streptomycin (100 /zg/ml) for 24 h before experiments. 
The glucose concentration of the culture medium was 5.6 
raM. Dispersed cells were prepared from the isolated islets 
using a procedure similar to that reported by Gobbe and 
Herchuelz [14]. In brief, after exposure to Ca 2÷- and 
Mg2÷-deprived medium, islets were disrupted using Dis- 
pase. Islet cells were collected by centrifugation and were 
re-suspended in RPMI-1640 medium supplemented with 
10% fetal bovine serum, 100 I .U./ml penicillin and 100 
/xg/ml streptomycin. These cells were seeded on poly-o- 
lysin-coated cover-slips and cultured for 2-4 days in an 
incubator with an atmosphere of 5% CO 2 in humidified 
air. 
2.2. Electrophysiology 
Membrane potentials were recorded using microelec- 
trodes as previously reported [15]. The electrical resistance 
of microelectrodes u ed was within the range of 300-400 
M ~2. A piece of freshly excised pancreas tissue containing 
one or two islets was fixed in a temperature-controlled 
perifusion chamber (volume, 0.5 ml), and perifused with 
KRB solution gassed with 95% 02 + 5% CO 2 mixture. 
/3-cells were identified by the typical electrical activity that 
they display in the presence of 11.1 mM glucose at 36°C. 
The flow rate was about 2 ml/min. The dead space of the 
system corresponds to approx. 30 s. The analog data was 
stored in video tapes after being digitized by a PCM 
processor (Sony PCM-501 modified, Tokyo). After experi- 
ments, the data were plotted on an XY-plotter (Roland 
DXY-980A, Hamamatsu). The time-lag due to the dead 
space was corrected in the figures. 
2.3. Measurements of  [Ca: + ]i 
Cultured cells attached on coverslips were incubated 
with 2 /zM fura-2/acetoxymethylester (Fu a-2/AM) for 
30-40 min in the Hanks' solution containing 5.6 mM 
glucose at 37°C. The loaded cells were then transferred 
into a temperature-controlled p rifusion chamber mounted 
on an inverted microscope quipped with a 40 × fluor 
objective (Nikon Diaphot). The cells were perifused at a 
flow rate of 2 ml/min with KRB solution. The delay of 
solution-change due to dead space has been approx. 2 min, 
and corrected in the figures. Perifusion solutions were kept 
at 36°C in a water bath. The dual wavelength fura-2 
micro-fluorometry was carried out by means of a time- 
sharing photometer (CAM 220 Nihon Bunko, Tokyo, 
Japan) connected to the inverted microscope. Excitation 
wave lengths were 340 and 380 nm, and the emission 
signal at 510 nm was detected by a photomultiplier. /3-cells 
were identified by the typical rise in the Fura-2 fluores- 
cence in response to extracellular glucose. The Ca 2÷ con- 
centration was calculated according to the method reported 
by Grynkewiz et al. [16] from the ratio of the intensities of 
fluorescence excited at 340 and 380 nm. 
2.4. Measurements of  reduced pyridine nucleotide fluores- 
cence 
The method of the measurement of reduced pyridine 
nucleotide fluorescence was essentially the same as that 
reported by Gilon and Henquin [12]. The perifusion cham- 
ber was identical to that used for measurement of [Ca 2+ ]i. 
The cells immunologically positive to anti-insulin antibody 
were large in size, and had many granules, whereas the 
cells immunologically positive to anti-glucagon antibody 
were small in size, and looked clearer. On the basis of 
these observations, fl-cells were identified under a micro- 
scope. All the perifusion solutions were kept at 36°C. The 
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reduced forms of NAD and NADP were excited at 360 
nm, and the fluorescence emitted through a dichroic mirror 
centered at 400 nm was filtered at 465 nm. The output of a 
photomultiplier was stored in analog FM data tapes. After 
experiment, the output of tile analog recorder was digitized 
at a sampling rate of 100 Hz, and plotted on an XY-plotter 
(Roland, Hamamatsu). In some cases, 10-25 consecutive 
items of data were averaged to reduce noise. The changes 
in NAD(P)H fluorescence were expressed as a percentage 
of control values obtained uring the last three rain preced- 
ing stimulation. 
2.5. Solutions 
A KRB solution used in this study had the following 
composition (in mM): 110 NaC1, 5 KC1, 2.5 CaC12, 1.1 
MgC12, 25 NaHCO 3, 5 HEPES, and constantly gassed 
with 95% 0 2 + 5% CO 2 (pH, 7.4). Glucose was added to 
the KRB solution. Osmolality was adjusted by subtracting 
NaC1 of corresponding moles. Test solutions containing 
glucagon were prepared by adding a small volume of the 
stock solution of glucagon (20 mg/ml) to test solutions. 
Stock solutions of CPZ, W-7, and TFP were prepared 
respectively by dissolving these drugs in DMSO to give 5 
mM. 
2.6. Chemicals 
Glucagon was purchased from Sigma Chemicals 
(St.Louis, USA). Dispase was from Godo-shusei (Tokyo, 
Japan). W-7 was purchased from Seikagaku Kogyou 
(Tokyo, Japan). Trifluoperazine, Chlorpromazine and col- 
lagenase were purchased from Woko Junnyaku (Osaka, 
Japan). Fura-2/AM was obtained from Dojin Kagaku 
(Kumamoto, Japan). All other chemicals were from Nacalai 
Tesque (Kyoto, Japan). 
2.7. Statistics 
Measured values were expressed as means +__ S.E.M. 
(sample number). 
3. Results 
3.1. Effect of  glucagon on electrical activity of  pancreatic 
[3-cells 
Glucagon has been reported to prolong the spike-burst 
periods and to shorten the silent phase interposed between 
spike-bursts at the intermediate high concentrations of 
glucose [3]. In this study, the dependency of the response 
on glucagon concentration was more systematically inves- 
tigated at various concentrations of glucose (from 2.8 mM 
to 11.1 mM). Fig. 1A shows typical electrical responses to 
glucagon (from 2.9 × 10 -8 M to 8.6 X 10 -7 M)  in the 
presence of 11.1 mM glucose. Traces shown in Fig. 1 were 
obtained from the same cell in an islet. At 2.9 × 10 -8 M 
of glucagon, the fraction of spike-burst periods was 0.36 +_ 
0.06 (initial five spike-bursts), and the fraction increased to 
0.78_ 0.08 (initial five spike-bursts) when glucagon in- 
creased to 8.6 × 10 -7 M. In the control solution without 
glucagon, the fraction was 0.26 + 0.01 (five spike-bursts). 
Experiments were repeated four times in different islets, 
and similar results were obtained. Averages of the spike- 
burst fractions (n = 4) at 11.1 mM glucose are plotted with 
respect to gtucagon concentration i  Fig. lB. Although the 
fraction of spike-burst periods increased with a rise in 
glucagon concentration, the best-fit curve was not a simple 
hyperbolic urve of the Michaelis-Menten type, suggesting 
the complexity behind the stimulating effect. When extra- 
cellular glucose concentration was 2.8 mM, /3-cells were 
in a resting state, and did not respond to glucagon at 
concentrations even as high as 8.6 X 10 -7 M (data not 
shown). 
3.2. Effect of  calmodulin-antagonists on glucagon-induced 
increase in intracellular Ca 2 + concentration 
A close relationship between the Ca 2+ oscillation and 
the electrical activity has been well documented 
[1:2,15,17-19]. From these observations, monitoring 
[ Ca2+ ]i instead of recording the membrane potential using 
a microelectrode may be considered to be a useful measure 
for detecting changes in electrical activity. Fig. 2 shows 
the typical effect of calmodulin-antagonists on the 
glucagon-evoked increase of intracellular Ca 2+. Chlor- 
promazine (CPZ), W-7, and trifluoperazine (TFP) were 
used for inhibiting the action of calmodulin. All the records 
were obtained from clusters consisting of 10-12 cells 
loaded with Fura-2. At least four experiments were carried 
out for each calmodulin-antagonist. 
Glucagon (2.9 × 10 -7 M) caused elevation in [Ca2+]i 
in the presence of 11.1 mM glucose, and made the Ca 2+ 
oscillation faster. This change in [Ca2+]~ seemed to be 
parallel to the change in electrical activity. When CPZ (10 
/xM) was added to the glucagon containing perifusion 
solution, the elevated [Ca 2+ ]i progressively fell down, and 
the regular hythmical oscillation reappeared (Fig. 2A). On 
removing CPZ, the frequency of Ca z+ oscillation in- 
creased again with gradual elevation of [Ca z + ]i to the level 
observed when glucagon alone had been added. Consecu- 
tive removal of glucagon brought about a restoration of the 
control oscillatory pattern with a decrease of background 
Ca 2 + level. In the absence of glucagon, CPZ had no effect 
on the Ca 2+ oscillation. When decreasing lucose from 
11.1 mM to 2.8 mM, [Ca2+ ]i fell down to the resting level. 
Fig. 2B shows the effect of W-7 on the glucagon-induced 
increase of [Ca 2+ ]i. W-7 of 15 /zM suppressed the stimu- 
lating effect of glucagon as well as CPZ of 10 /xM. In the 
absence of glucagon, W-7 had no effect on [Ca2+]i either 
(Fig. 2B, lower trace), suggesting that in the absence of 
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glucagon these calmodulin-antagonists do not induce any 
change in the electrical activity. In separate experiments 
using a microelectrode, W-7 had no effect on the electrical 
activity in the absence of  glucagon, whereas this drug 
reversed the glucagon-induced enhancement of  electrical 
activity (data not shown). Fig. 2C illustrated the effect of  
TFP (30 /zM) on [Ca 2÷ ]i in the presence of  glucagon. 
When TFP was added to the perifusion solution, the 
glucagon-evoked increase of  intracellular Ca 2+ gradually 
decreased, and the typical Ca 2+ oscil lation reappeared. 
Upon removing TFP, [Ca2+]i elevated again to the level 
before TFP had been added. 
The fact that all these drugs have similarly suppressed 
the glucagon-evoked increase of  intracellular Ca 2÷ sup- 
ports the view that the Ca2+/ca lmodul in  system is in- 
volved somewhere in the pathway through which glucagon 
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Fig. 1. Effect of glucagon on electrical activity of pancreatic r-cells. (A) Intracellular recording of electrical activity at various concentrations of glucagon 
(2.9 × 10 -s to 8.6 × 10 -7 M). Glucose concentration is 11.1 mM in all the traces. Glucagon was added to the perifusion solution for the periods indicated 
with a horizontal bar in each trace. Glucagon concentrations are noted on bars. Four traces are a continuous record from the same cell in an islet. This 
record is representative of the results of four similar experiments conducted in different islets. Temperature was 36°C. (B) A graph illustrating the 
relationship between the fraction of spike-burst periods and glucagon concentrations. Each point indicates the mean of four experiments. Vertical bars 
show S.E.M. A curve was drawn by eye. 
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exerts its stimulating effect on the electrical activity of the 
/3-cell. 
3.3. Effects of glucagon on NAD(P)H fluorescence in the 
presence or absence of extracellular Ca 2 ÷ 
It is established that glucagon induces glycogenolysis in
the hepatic ells [20]. In order to examine whether glucagon 
induces a change in the glucose supply from glycogen 
stores in the /3-cells as well as in the liver parenchymal 
cells, changes in NAD(P)H content were traced by measur- 
ing the intensity of emission filtered at 465 nm of the 
autofluorescence excited ;it 360 nm. Fig. 3 shows typical 
changes of NAD(P)H autofluorescence in cell clusters. 
Raising extracellular glucose concentration from 2.8 to 
11.1 mM brought about a marked increase of the autofluo- 
rescence (141 ___ 16% of the level at 2.8 mM of glucose, 
n = 5). The increase of NAD(P)H fluorescence induced by 
raising glucose concentration scarcely depended on the 
presence of extracellular Ca 2+ in accordance with the 
previous report [21], though in the absence of extracellular 
Ca 2÷ the glucagon-evoked rise in NAD(P)H fluorescence 
was slightly slower in onset in this example. This finding 
will be discussed later. Under steady-state stimulation with 
11.1 mM glucose, glucagon of 8.6 × 10 -8 M caused a 
further increase of NAD(P)H fluorescence in the presence 
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Fig. 2. Effects of calmodulin-antagonists on the glucagon-induced increase in intracellular Ca 2+ concentration. Intracellular Ca 2+ concentration was 
estimated from the fluorescence ratio of Fura-2 in the islet cell cluster. (A) Suppression f glucagon-induced [Ca 2+ ]i increase by chlorpromazine (CPZ). 
Glucose concentration was changed from 2.8 mM to 11.1 raM. When extracellular glucose was 11.1 mM, glucagon (2.9 × 10 -7 M) was added to the 
perifusion solution for the period indicated with a horizontal bar. CPZ (10/.~M) was added twice; once in the presence and once in the absence ofglucagon 
as indicated with horizontal bars, respectively. (B) Suppression f glucagon-induced [Ca 2+ ]i increase by W-7. W-7 was added twice as indicated by two 
horizontal bars for the period of exposure to glucagon, and once for the period without glucagon as indicated in a lower trace. (C) Suppression f 
glucagon-induced [Ca 2+ ]i increase by trifluoperazine (TFP). TFP (30 /xM) was added to the glucagon-containing perifusion solution for the period 
indicated by a horizontal bar. The records A, B and C were obtained from different cell-clusters. Temperature was 34°C. 
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of  2.5 mM Ca  2÷ (182_18% o f  the  level  at 2.8 mM 
g lucose ,  n = 5), whereas  in the  absence  o f  ex t race l lu la r  
Ca  2 ÷ g lucagon had  little e f fec t  on  NAD(P)H  f luorescence .  
These  f ind ings  ind icate  that  Ca  2+ is ind ispensab le  for  
g lucagon to exer t  its s t imu la t ing  e f fect  on  g lucose  
metabo l i sm even  in the /3-cell. 
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Fig. 3. Effect of glucagon on NAD(P)H fluorescence in the presence or absence of extracellular Ca 2+. NAD(P)H in the cell-cluster was excited at 360 nm, 
and the fluorescence emitted through a filter centered at 465 nm was recorded. Upper trace represents he change in NAD(P)H fluorescence in the presence 
of 2.5 mM Ca 2+. Lower trace is that in the absence of Ca 2 ÷. Glucose concentration was changed from 2.8 mM to 11. l mM and again to 2.8 mM as shown 
in the figure. Glucagon (8.6 X 10 -8 M) was present for the period indicated with a horizontal bar in each trace. Control values were obtained uring the 
last three min in 2.8 mM glucose perifusion solution. These two traces were recorded from the same cell-cluster cultured for two days. Temperature was 
34°C. Traces shown in this figure are representative of records in five similar experiments conducted in different preparations. 
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Fig. 4. Effects of Ca2+-removal nd calmodulin-antagonists on the glucagon-induced increase of NAD(P)H fluorescence. NAD(P)H fluorescence 
measurements were done in islet cell clusters. In the upper two traces (A and B), glucose concentration was changed from 2.8 mM to 11.1 mM then again 
to 2.8 mM as indicated in traces. In the lower two traces (C and D), glucose concentration was 11.1 mM. Glucagon (8.6 × 10 -8 M) was present in the 
perifusion solution for the period indicated with a horizontal bar in each trace. Control values were obtained uring the last three min in 11.1 mM glucose 
perifusion solution preceding stimulation with glucagon. (A) Suppression of glucagon-induced NAD(P)H increase by extracellular Ca 2+ removal. (B) 
Suppression of glucagon-induced NAD(P)H increase by CPZ (10 p,M). (C) Suppression by W-7 (15/zM); and (D) suppression by TFP. These four records 
were obtained from different preparations. Temperature was 34°C. Similar experiments were conducted in four different preparations. 
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3.4. Effects of calmodulin-antagonists on the glucagon-in- 
duced increase of NAD(P)Hfluorescence 
Cellular events which are mediated with Ca 2+ as a 
second messenger f equently require calmodulin or Ca 2+- 
binding protein [20]. The finding that calmodulin- 
antagonists have suppressed the effect of glucagon on 
[Ca2+]i suggests that the Ca2+-binding protein plays an 
important role in expressing the glucagon effect. In order 
to evaluate the extent of its involvement in the regulation 
of glucose metabolism by glucagon, the effect of calmod- 
ulin-antagonists on the glucagon-induced increase of 
NAD(P)H fluoresccence was investigated in islet cell clus- 
ters. In advance of conducting experiments with calmod- 
ulin-antagonists, fluorescence hanges induced by extracel- 
lular Ca 2+ removal during the period of exposure to 
glucagon (8.6 X 10 -8 M) were examined. Glucose concen- 
tration was 11.1 mM. As shown in Fig. 4A, in the presence 
of glucagon extracellular Ca 2+ removal decreased the 
NAD(P)H fluorescence. Four min after removing extracel- 
lular Ca 2+, the fluorescence r ached a steady level which 
was slightly lower than the level attained before glucagon 
had been added. The level attained preceding lucagon- 
stimultion is taken as the control level hereafter. After 
switching back to the Ca 2 +-containing perifusion solution, 
NAD(P)H fluorescence recovered to the level attained 
before removing extracellular Ca 2+. Similar findings were 
obtained in three other experiments. Next, the effect of 
calmodulin-antagonists on the glucagon-stimulated 
NAD(P)H fluorescence was investigated. Fig. 4B shows 
the effect of CPZ (10 k~M) on the glucagon-stimulated 
NAD(P)H fluorescence. In preliminary experiments long 
exposure to calmodulin-antagonists sometimes induced an 
irreversible change in NAD(P)H fluorescence. To avoid 
such an irreversible change in the fluorescence, the expo- 
sure to calmodulin-antagonist was limited within four min. 
When glucagon alone we,s present in the perifusion solu- 
tion containing 11.1 mM glucose, the level of NAD(P)H 
fluorescence was 122 _+ 6 (n = 4) of the control level in 
this series of experiments. During four min exposure to 
CPZ the glucagon-stimulated NAD(P)H fluorescence de- 
creased to a level slightly higher (111 _+ 5%, n = 4) than 
the control evel. After removal of CPZ, the fluorescence 
completely recovered. The complete recovery indicates 
that the cells examined are still in good condition. Both 15 
/,M W-7 and 30 /zM TOP induced a fall in the reduced 
pyridine nucleotide fluorescence. In experiments with W-7, 
the glucagon-stimulated florescence decreased from 137 _ 
6% (n=4)  of the control level to 121+5% (n=4)  
during four min exposure to W-7, and completely recov- 
ered to the initial level after removal of W-7 (Fig. 4C). 
Fig. 4D shows the effect of TFP on glucagon-stimulated 
NAD(P)H fluorescence. Two min exposure to TFP in- 
duced a decrease of the fluorescence from 136 +_ 6% to 
124 +_ 5% (n = 4) of the control. After TFP was removed, 
the fluorescence intensity returned to the initial level held 
before this antagonist had been added. Although the mag- 
nitudes of the decrease in fluorescence intensity induced 
by calmodulin-antagonists were small, a clear change in 
the fluorescence intensity was always observed in every 
trace. The relatively weak effect of these antagonists may 
partly be due to the incomplete progress of inhibition 
within the period of exposure to these antagonists. In the 
absence of glucagon, these calmodulin-antagonists did not 
cause any significant changes in NAD(P)H fluorescence 
(data not shown). The ineffectiveness of calmodulin- 
antagonists when glucagon does not exist accords with the 
observations made on [Ca2+] i when calmodulin antago- 
nists were added to the glucagon-free perifusion solution 
(Fig. 2). 
From observations presented above it may be possible 
to deduce the following view that the Ca2+/calmodulin 
system is involved in the glucagon-induced acceleration of
NAD(P)H production, which leads to an activation of 
electrical activity through the elevation of ATP/ADP ratio 
in consequence of an increase in ATP production. 
4. Discussion 
Present experiments demonstrated that glucagon caused 
an increase in the autofluorescence of reduced pyridine 
nucleotides, NAD(P)H, in the presence of extracellular 
Ca 2+. The stimulation by glucagon of insulin secretion 
from /3-cells has been demonstrated in purified /3-cell 
preparations [4,22]. It is widely accepted that under physio- 
logical conditions insulin secretion is mediated by the 
electrical response accompanied by a rise in [Ca2+] i 
[12,15,17-19,23,24]. On the basis of this well defined 
story, it may be reasonable to speculate that the glucagon- 
induced increase of insulin secretion also is mediated by 
an enhancement of electrical activity. As shown in Fig. 1, 
the enhancement of electrical activity evoked by glucagon 
resembles that induced by an increase of extracellular 
glucose. This similarity suggests that glucagon exerts its 
effect hrough decreasing the background K + conductance, 
as a rise in glucose concentration. It has been demonstrated 
that glucagon increases intracellular cAMP in isolated 
/3-cells [4,25]. In connection with these reports, both 
forskolin, adenylate cyclase activators [5,6], and dibutylyl 
cAMP [26] have been reported to induce the change in 
electrical activity similar to that induced by glucagon. 
These reports indicate that the glucagon-induced nhance- 
ment of electrical activity is mediated by an increase of 
cAMP. At present, there is no report supporting direct 
involvement of PKA-mediated phosphorylation in closings 
of K(ATP) channels. This situation suggests that control 
mechanisms other than the direct modification of channel 
molecules remain to be searched for. It is well defined that 
an increase in intracellular ATP or ATP/ADP ratio causes 
closure of ATP-sensitive K-- channels [27,28]. A rise in 
extracellular glucose concentration i creases ATP content 
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in islets [29]. A breakdown of intracellular glycogen may 
also provide additional fuel for ATP synthesis. It is estab- 
lished that in liver cells glucagon activates adenylate cy- 
clase, leading to an increase of cAMP, and that the acti- 
vated PKA stimulates phosphorylase kinase whose sub- 
strate is glycogen phosphorylase [20]. In skeletal muscle 
the activation of phosphorylase kinase requires both cAMP 
and Ca 2+ [30]. At present, the 6-subunit of the enzyme is 
identified as calmodulin [31]. Although the reported 
molecular weight of intracellular f actions phosphorylated 
by PKA in islets are much smaller than that of phospho- 
rylase kinase [8], this substrate of small molecular weight 
is accountable if only the dissociated a-subunits are phos- 
phorylated. In the light of much knowledge with regard to 
the hormonal action on glycogenolysis, there is no reason 
to exclude the possibility that the same things might occur 
in /3-cells as in skeletal muscle. Strong evidence support- 
ing this view is found in the report by Idahl and Hellman 
[32] that dibutylyl cAMP reduces the content of glycogen 
in isolated pancreatic islets. 
Present study has demonstrated for the first time that 
glucagon increases NAD(P)H fluorescence and this stimu- 
lating effect is suppressed by either Ca 2+ removal or 
calmodulin-antagonists n pancreatic islet cells. Since all 
the antagonists used in this study have shown the same 
suppressing effect on the glucagon-induced increase of 
NAD(P)H as Ca 2+ removal, it may be possible to consider 
that CaZ+/calmodulin system is involved in the glucagon- 
evoked cAMP-mediated acceleration of glycogenolysis. 
Pralong et at. reported that EGTA (3 mM) in the perifusion 
solution caused a small decrease of NAD(P)H fluorescence 
in a single isolate /3-ceil [13]. In one experiment of ours, a 
slight decrease of NAD(P)H fluorescence was observed 
when extracellular Ca 2 + was removed even in the absence 
of glucagon. This finding might indicate that in accelera- 
tion of glycogenolysis there is another pathway which 
solely depends on the Ca2+/calmodulin system beside the 
pathway dependent on both cAMP and the 
CaZ+/calmodulin system, or that cAMP is high in some 
cells. However, from the result of present study that in 
Ca2+-free perifusion solution the effect of glucagon on 
NAD(P)H content has completely been suppressed (Fig. 
3), the contribution of the pathway solely dependent on 
Ca2+/calmodulin system is considered to be less than that 
of the latter, even if the former pathway exists. 
KN-62, a specific inhibitor of the cag+/calmodulin-de - 
pendent protein kinase II, has been reported by Li et al. 
[33] to block the voltage-dependent Ca z+ channel, and to 
suppress the nutrient-induced [Ca2+] i increase. The prein- 
cubation with CGS 9343B, a calmodulin-antagonist, is also 
reported to suppress the nutrient-induced [Ca z+ ]i increase 
in the same paper. From the similarity between the effects 
of these two drugs on the nutrient-induced [Ca 2÷ ]i in- 
crease, they suggested that calmodulin-antagonist blocks 
the voltage-dependent Ca 2÷ channels. In contrast o their 
findings, in the present experiments calmodulin-antagonists 
were not found to exert effect on Ca  2+ oscillation in the 
absence of glucagon. Since direct evidence indicating the 
blocking effect of calmodulin-antagonist is lacking at pre- 
sent, their result cannot exclude the possibility that CGS 
9343B suppresses Ca 2 +/calmodulin-dependent glycogeno- 
lytic pathway in their preparation. The suppression of 
glycogenolytic pathway causes a decrease of NAD(P)H, 
and the resultant decrease in ATP production fails in 
evoking depolarization, leading to a suppression of the 
nutrient-induced [Ca 2+ ]i increase as a consequence of no 
spike generation. By the way, CGS 9343B is reported to 
partially inhibit the nutrient-evoked insulin-secretion in the 
presence of forskolin, while in the absence of forskolin the 
inhibitory effect was much smaller [33]. This finding rather 
accords with our view. Glucagon-like peptide-1, a gut 
incretin factor [34], also may exert its effect through a 
pathway similar to that which has been suggested above. 
At low concentrations of glucose, the insulin release is 
low even though glucagon is secreted from a-cells in the 
same islet. The involvement of CaZ+/calmodulin system 
in the glucagon action may give an account for this 
relative ineffectiveness of glucagon as follows: at low 
glucose concentrations r-cells are in the resting state, i.e., 
[Ca2+] i is so low that the activation of phosphorylase 
kinase is prevented in spite of high cAMP. When extracel- 
lular glucose increases, Ca2+-spikes are elicited on a depo- 
larization. The increased Ca2+-influx results in an eleva- 
tion of [Ca 2÷ ]i, leading to an activation of enzymes re- 
sponsible for glycogenolysis, which are dependent on both 
cAMP and Ca2+/calmodulin system. The additional glu- 
cose supply from glycogen stores initiated by the activa- 
tion of glycogen phosphorylase may intrinsically be related 
to the generation of relatively long-lasting initial spike-train 
(initial phase) which precedes the rhythmical occurrence of 
spike-bursts (second phase) commonly observed in re- 
sponse to a sudden rise in extracellular glucose concentra- 
tion. High concentrations of glucose suppress the 
glucagon-secretion from a-cells, leading to the deactiva- 
tion of enzymes related to glycogenolysis. Both the de- 
crease of glucose supply and a rise of ATP consumption 
may cause a fall of ATP/ADP ratio which terminates the 
initial phase. Although further study is needed to substanti- 
ate the above proposed story, the activation of enzymes by 
the co-operation of cAMP and Ca2+/calmodulin system 
may play a crucial role in the formation of a bi-phasic 
pattern of an insulin release response to glucose. 
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